The Allosteric Antagonist of the Sigma-2 Receptors—Elayta (CT1812) as a Therapeutic Candidate for Mild to Moderate Alzheimer’s Disease: A Scoping Systematic Review

por Rasheed, Anum, Zaheer, Ahmad Bin, Munawwar, Aqsa, Sarfraz, Zouina, Sarfraz, Azza, Robles-Velasco, Karla, Cherrez-Ojeda, Ivan
Publicado 2022